Back to Sites

PHRU Matlosana

Site Number

31976

Address

Tshepong Hospital
Benji Oliphant Rd
MDR TB Unit
Klerksdorp, Matlosana 2574
South Africa

IMPAACT Members at this Site

Tumelo Moloantoa CRS Coordinator

Katlego Motlhaoleng CRS Coordinator

Neil Martinson CRS Leader

Fatima Mayat CTU Coordinator

Glenda Gray CTU Principal Investigator

Lerato Mohapi CTU Principal Investigator

Ravindre Panchia CTU Principal Investigator

Studies at this Site

P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV

DAIDS Number

Research Area

Study Status

Closed to Accrual

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Accrual

IMPAACT 2020: Phase II Study of Shortened Oral Treatment for Rifampicin-Resistant Tuberculosis in Children

DAIDS Number

Research Area

Study Status

IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status